The role of the GPR39 receptor in zinc deficient-animal model of depression

Leonard, 2012, Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression, Neuroscience & Biobehavioral Reviews, 36, 764, 10.1016/j.neubiorev.2011.12.005 Maes, 2011, A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 676, 10.1016/j.pnpbp.2010.05.004 Maes, 2011, Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways, Neuroendocrinology Letters, 32, 7 Maes, 1997, Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness, Biological Psychiatry, 42, 349, 10.1016/S0006-3223(96)00365-4 Maes, 1999, Lower serum zinc in major depression in relation to changes in serum acute phase proteins, Journal of Affective Disorders, 56, 189, 10.1016/S0165-0327(99)00011-7 McLoughlin, 1990, Zinc in depressive disorder, Acta Psychiatrica Scandinavica, 82, 451, 10.1111/j.1600-0447.1990.tb03077.x Maes, 1994, Hypozincemia in depression, Journal of Affective Disorders, 31, 135, 10.1016/0165-0327(94)90117-1 Siwek, 2010, Serum zinc level in depressed patients during zinc supplementation of imipramine treatment, Journal of Affective Disorders, 126, 447, 10.1016/j.jad.2010.04.024 Maes, 1995, Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression, Journal of Affective Disorders, 34, 301, 10.1016/0165-0327(95)00028-L Maes, 2006, Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS, Journal of Affective Disorders, 90, 141, 10.1016/j.jad.2005.11.002 Kroczka, 2000, Zinc exhibits an antidepressant-like effect in the forced swimming test in mice, Polish Journal of Pharmacology, 52, 403 Kroczka, 2001, Antidepressant-like properties of zinc in rodent forced swim test, Brain Research Bulletin, 55, 297, 10.1016/S0361-9230(01)00473-7 Siwek, 2009, Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study, Journal of Affective Disorders, 118, 187, 10.1016/j.jad.2009.02.014 Lai, 2012, The efficacy of zinc supplementation in depression: systematic review of randomized controlled trials, Journal of Affective Disorders, 136, e31, 10.1016/j.jad.2011.06.022 Sensi, 2009, Zinc in the physiology and pathology of the CNS, Nature Reviews Neuroscience, 10, 780, 10.1038/nrn2734 Frederickson, 2005, The neurobiology of zinc in health and disease, Nature Reviews Neuroscience, 6, 449, 10.1038/nrn1671 Takeda, 2012, Significance of serum glucocorticoid and chelatable zinc in depression and cognition in zinc deficiency, Behavioural Brain Research, 226, 259, 10.1016/j.bbr.2011.09.026 Frederickson, 2006, Synaptic release of zinc from brain slices: factors governing release, imaging, and accurate calculation of concentration, Journal of Neuroscience Methods, 154, 19, 10.1016/j.jneumeth.2005.11.014 Skolnick, 1999, Antidepressants for the new millennium, European Journal of Pharmacology, 375, 31, 10.1016/S0014-2999(99)00330-1 Skolnick, 2009, Glutamate-based antidepressants: 20 years on, Trends in Pharmacological Sciences, 30, 563, 10.1016/j.tips.2009.09.002 Rosa, 2003, Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice, Behavioural Brain Research, 144, 87, 10.1016/S0166-4328(03)00069-X Sowa-Kućma, 2008, Antidepressant-like activity of zinc: further behavioural and molecular evidence, Journal of Neural Transmission, 115, 1621, 10.1007/s00702-008-0115-7 Szewczyk, 2010, Involvement of NMDA and AMPA receptors in the antidepressant-like activity of zinc in the forced swim test, Amino Acids, 39, 205, 10.1007/s00726-009-0412-y Loix, 2011, The anti-inflammatory effects of ketamine: state of the art, Acta Anaesthesiologica Belgica, 62, 47 Chang, 2009, Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation, Mediators of Inflammation, 2009, 705379, 10.1155/2009/705379 Lauwers, 2006, Obestatin does not activate orphan G protein-coupled receptor GPR39, Biochemical and Biophysical Research Communications, 351, 21, 10.1016/j.bbrc.2006.09.141 Holst, 2007, GPR39 signaling is stimulated by zinc ions but not by obestatin, Endocrinology, 148, 13, 10.1210/en.2006-0933 Yasuda, 2007, A Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum, Journal of Receptors and Signal Transduction Research, 27, 235, 10.1080/10799890701506147 Besser, 2009, Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus, Journal of Neuroscience, 29, 2890, 10.1523/JNEUROSCI.5093-08.2009 McKee, 1997, Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors, Genomics, 46, 426, 10.1006/geno.1997.5069 Howard, 2001, Orphan G-protein-coupled receptors and natural ligand discovery, Trends in Pharmacological Sciences, 22, 132, 10.1016/S0165-6147(00)01636-9 Zhang, 2005, Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake, Science, 310, 996, 10.1126/science.1117255 Tremblay, 2007, Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39, Endocrinology, 148, 501, 10.1210/en.2006-1275 Hershfinkel, 2001, A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport, Proceedings of the National Academy of Sciences United States of America, 98, 11749, 10.1073/pnas.201193398 Holst, 2004, Common structural basis for constitutive activity of the ghrelin receptor family, Journal of Biological Chemistry, 279, 53806, 10.1074/jbc.M407676200 Alboni, 2011, Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice, Neuropharmacology, 60, 1337, 10.1016/j.neuropharm.2011.01.050 Neto, 2011, Neurotrophins role in depression neurobiology: a review of basic and clinical evidence, Current Neuropharmacology, 9, 530, 10.2174/157015911798376262 Porsolt, 1977, Behavioural despair in mice: a primary screening test or antidepressants, Archives Internationales de Pharmacodynamie et de Therapie, 229, 327 Nowak, 2003, Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats, Brain Research Bulletin, 61, 159, 10.1016/S0361-9230(03)00104-7 Cieślik, 2007, Influence of zinc suplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats, Pharmacological Reports, 59, 46 Cieślik, 2011, Chronic unpredictable stress-induced reduction in the hippocampal brain derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment, Pharmacological Reports, 63, 537, 10.1016/S1734-1140(11)70520-5 Młyniec, 2012, Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test, Pharmacological Reports, 64, 567, 10.1016/S1734-1140(12)70852-6 Młyniec, 2012, Zinc deficiency induces behavioral alterations in the tail suspension test in mice Effect of antidepressants, Pharmacological Reports, 64, 249, 10.1016/S1734-1140(12)70762-4 Tassabehij, 2008, Zinc deficiency induces depression-like symptoms in adult rats, Physiology & Behavior, 95, 365, 10.1016/j.physbeh.2008.06.017 Whittle, 2009, Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice, Amino Acids, 36, 147, 10.1007/s00726-008-0195-6 Skolnick, 1996, Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression, Pharmacopsychiatry, 29, 23, 10.1055/s-2007-979537 Paul, 2003, Glutamate and depression: clinical and preclinical studies, Annals of the New York Academy of Sciences, 1003, 250, 10.1196/annals.1300.016 Takeda, 2005, Involvement of unusual glutamate release in kainate-induced seizures in zinc-deficient adult rats, Epilepsy Research, 66, 137, 10.1016/j.eplepsyres.2005.07.011 Takeda, 2011, Zinc signaling in the hippocampus and its relation to pathogenesis of depression, Molecular Neurobiology, 44, 166, 10.1007/s12035-010-8158-9 Cichy, 2009, Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors, Pharmacological Reports, 61, 1184, 10.1016/S1734-1140(09)70182-3 Nibuya, 1995, Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments, Journal of Neuroscience, 15, 7539, 10.1523/JNEUROSCI.15-11-07539.1995 Larsen, 2010, Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment, Journal of Psychiatric Research, 44, 808, 10.1016/j.jpsychires.2010.01.005 Maes, 2012, New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways And new drug candidates—Nrf2 activators and GSK-3 inhibitors, Inflammopharmacology, 20, 127, 10.1007/s10787-011-0111-7 Gervasoni, 2005, Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode, Neuropsychobiology, 51, 234, 10.1159/000085725 Kurita, 2012, Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study, PLoS One, 7, e39212, 10.1371/journal.pone.0039212 Popovics, 2011, GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions, Cellular and Molecular Life Sciences, 68, 85, 10.1007/s00018-010-0517-1 Chang, 2004, A novel role for serum response factor in neuronal survival, Journal of Neuroscience, 24, 2277, 10.1523/JNEUROSCI.4868-03.2004 Tardito, 2006, Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview, Pharmacological Reviews, 58, 115, 10.1124/pr.58.1.7 Duman, 1999, Neural plasticity to stress and antidepressant treatment, Biological Psychiatry, 46, 1181, 10.1016/S0006-3223(99)00177-8